Covered recipient · General Payments record
RANDI M ROTHSTEIN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,596.68
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.58 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $81.70 | 5 |
| Organon LLC | $59.16 | 5 |
| Sumitomo Pharma America, Inc. | $49.71 | 2 |
| PFIZER INC. | $33.58 | 2 |
| CooperSurgical, Inc. | $24.47 | 1 |
| MILLICENT US INC | $22.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $15.03 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277322 | CMS |
| Astellas Pharma US Inc | $18.67 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139285442 | CMS |
| Astellas Pharma US Inc | $14.53 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371573 | CMS |
| Astellas Pharma US Inc | $16.48 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139420707 | CMS |
| Astellas Pharma US Inc | $16.99 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139441752 | CMS |
| CooperSurgical, Inc. | $24.47 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150789107 | CMS |
| MILLICENT US INC | $22.96 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911546 | CMS |
| Organon Llc | $22.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282864 | CMS |
| Organon Llc | $1.88 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282875 | CMS |
| Organon Llc | $18.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282879 | CMS |
| Organon Llc | $14.38 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282868 | CMS |
| Organon Llc | $1.39 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282871 | CMS |
| PFIZER INC. | $18.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131307619 | CMS |
| PFIZER INC. | $15.53 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131639867 | CMS |
| Sumitomo Pharma America, Inc. | $23.67 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912202 | CMS |
| Sumitomo Pharma America, Inc. | $26.04 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148912204 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.